These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Cyclic hormonal treatment in ovarian cancer. A phase-II trial.
    Author: Jakobsen A, Bertelsen K, Sell A.
    Journal: Eur J Cancer Clin Oncol; 1987 Jul; 23(7):915-6. PubMed ID: 2959486.
    Abstract:
    Twenty-nine patients with advanced epithelial ovarian cancer were included in a phase-II trial of cyclic hormonal treatment. The schedule consisted of tamoxifen 10 mg X 3 daily for 14 days followed by medroxyprogesterone acetate 400 mg X 2 daily for 14 days. No objective response was recorded in 17 evaluable patients and cyclic hormonal treatment appears to be ineffective in advanced ovarian cancer.
    [Abstract] [Full Text] [Related] [New Search]